Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Treating PCOS With Semaglutide vs Active Lifestyle Intervention [Phase 2, Phase 3]
Phase 2/Phase 3 trial comparing semaglutide to active lifestyle intervention for polycystic ovary syndrome has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk [Phase 2]
Phase 2 results have been posted for a growth hormone releasing hormone analog aimed at improving non-alcoholic fatty liver disease and asso…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity [NA]
A completed clinical trial from Universidad de Granada evaluated time-restricted eating and exercise on cardiometabolic health in individual…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus [NA]
This completed clinical trial evaluated blood-test screening for liver fibrosis in people with Type 2 diabetes mellitus. The study included …
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease [NA]
A completed feasibility study evaluated the use of an immersive virtual reality dietitian program for adults with non-alcoholic fatty liver …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH [Phase 2]
Phase 2 dose exploration trial of GSK4532990 in participants with non-alcoholic fatty liver disease, including NASH or suspected NASH, has c…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study to Evaluate the Effectiveness of Legalon®
A completed clinical trial sponsored by Mylan Inc. evaluating the effectiveness of Legalon® for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease [NA]
A clinical trial evaluating motivational interviewing for managing non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort) [NA]
The FreSH Cohort study in France, evaluating non-invasive tests for liver lesions in non-alcoholic fatty liver disease (NAFLD/NASH), has com…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Ultrasound Liver Fat Quantification on Pediatric Patients [NA]
Clinical trial update shows completion of a pediatric ultrasound liver fat quantification study sponsored by Philips China.
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating Jing-Si Herbal Tea for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: The Effect of GLP-1 Analogues on Liver Steatosis and Fibrosis in Diabetic and Obese Patients in a Clinical Setting
A completed clinical trial reports results on the effect of GLP-1 analogue treatment on liver fat accumulation and fibrosis in patients with…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases [Phase 4]
Phase 4 clinical trial evaluating alpha-lipoic acid for non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial comparing Obeticholic Acid with Vitamin E in non-alcoholic fatty liver disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial assessing the effect of an adjustable intragastric balloon in obese individuals with non-alcoholic fatty liver di…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluated a probiotic supplement versus placebo for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Knockdown of HSD17B13 mRNA, Pharmacokinetics, Safety, and Tolerability, of AZD7503 in Non-Alcoholic Fatty Liver Disease [Phase 1]
Phase 1 trial evaluating AZD7503 for HSD17B13 mRNA knockdown with pharmacokinetics, safety, and tolerability data in non-alcoholic fatty liv…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load [Phase 4]
A Phase 4 trial assessed the efficacy and safety of a rilpivirine-based antiretroviral regimen in HIV-infected patients with non-alcoholic f…
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Lifestyle Guidance Methods in NAFLD [NA]
A completed clinical trial evaluating lifestyle guidance methods for non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Prevalence of NAFLD in ACS Patients [NA]
This clinical trial update reports the prevalence of non-alcoholic fatty liver disease in patients with acute coronary syndrome and notes th…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) [Phase 4]
Phase 4 trial update on metformin for ectopic fat deposition and metabolic markers in polycystic ovary syndrome; the study was terminated an…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Implementation of the Fatty Liver Index in Primary Care [NA]
Completed clinical trial evaluating the implementation of the Fatty Liver Index in primary care to screen for hepatic steatosis among patien…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Low-Calorie Diet in People With Prediabetes/Metabolic Syndrome [NA]
A completed clinical trial evaluating a low-calorie diet in people with prediabetes and metabolic syndrome, with obesity and non-alcoholic f…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Liver Health and Metabolic Function in People With Obesity [NA]
A completed clinical trial evaluating liver health and metabolic function in people with obesity. The study focuses on Non-Alcoholic Fatty L…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan
A completed clinical trial evaluating liver stiffness and hepatic steatosis in women with polycystic ovary syndrome using FibroScan.